USFDA conducts pre-approval inspection at Lupin’s Pune Biotech facility

20 Sep 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has conducted a product-specific Pre-Approval Inspection at Lupin’s Pune Biotech facility. The inspection has been conducted from September 08 to September 19, 2025. The inspection closed with four observations.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2102.50 10.55 (0.50%)
05-Dec-2025 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.00
Dr. Reddys Lab 1276.05
Cipla 1521.20
Zydus Lifesciences 931.85
Lupin 2102.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×